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ABSTRACT Prion diseases are thought to result from a pathogenic, conformational change in a cellular protein, the prion
protein. The pathogenic isoform seems to convert the normal isoform in an autocatalytic process. In contrast to the conditions
used for in vitro studies of enzyme kinetics, the concentration of the catalyst is not much lower than that of the substrate in
the course of infection. This feature may endow the system with a time-hierarchy allowing the pathogenic isoform to relax very
slowly in the course of infection. This may contribute to the long incubation periods observed in prion diseases. The dynamic
process of prion propagation, including turnover of the cellular prion protein, displays bistable properties. Sporadic prion
diseases may result from a change in one of the parameters associated with metabolism of the prion protein. The bistable
transition observed in sporadic disease is reversible, whereas that observed in cases of exogenous contamination is
irreversible. This model is consistent with the occurrence of rare, sporadic forms of prion diseases. It may also explain why
only some individuals of a cohort develop a prion disease following transient food contamination.
INTRODUCTION
There is compelling biochemical and genetic evidence
(Prusiner, 1991; Bessen et al., 1995; Laurent and Johannin,
1997; Prusiner et al., 1998) to suggest that the agent respon-
sible for the onset and propagation of transmissible spon-
giform encephalopathies (or prion diseases) is a pathogenic
conformational isoform (PrPSc) of a protein encoded by a
host gene (the prion protein, PrPC). The pathogenic isoform
is thought to multiply by converting the normal protein into
a copy of itself in an autocatalytic process (Telling et al.,
1996; Laurent, 1997). The frequency of spontaneous con-
version of PrPC into PrPSc is thought to be very low,
accounting for the low incidence of sporadic prion diseases.
However, inherited mutations in the Prp gene (leading to
familial prion diseases) are likely to increase the frequency
of the conversion, facilitating spontaneous expression of the
disease within the lifetime of the individual.
Model studies (Laurent, 1996; Kacser and Small, 1996;
Kepler, 1997; Porcher and Gatto, 2000) have shown that, in
a physiological context including turnover of the normal
isoform of the protein and its circulation through several
cellular compartments, prion propagation corresponds to a
switch between a normal and a pathogenic, alternative sta-
ble steady state (i.e., the system exhibits bistability). The
dynamic component of mechanisms of protein conforma-
tional changes can help us to understand threshold proper-
ties of infection and contamination, the characteristics of
interspecies transmission of prion diseases or the existence
of a species barrier (Laurent, 1998; Kellershohn and Lau-
rent, 1998). However, in all the models studied to date,
phenomenological rate laws (derived from enzymatic catal-
ysis) have been used to express the kinetics of conversion of
PrPC into PrPSc. These rate laws are valid only in conditions
in which the concentration of the catalyst is much lower
than that of the substrate. Clearly, this is only likely to be
the case during the initial period of prion infection. As the
conversion process progresses, the ratio of pathogenic to
normal forms of the prion protein increases and the PrPSc
isoform soon becomes predominant.
Attempts have been made to deal with situations of this
type for enzyme catalysis (Halfman and Marcus, 1982;
Laurent and Kellershohn, 1984; Kellershohn and Laurent,
1985). This concentration effect has been shown to modify
profoundly the co-operative properties of multimeric en-
zymes. This situation closely resembles that for prions,
because several lines of evidence (Bellinger-Kawahara et
al., 1988; Sklaviadis et al., 1989, 1992; Jarret and Lansbury,
1993; Come et al., 1993; Eigen, 1996; Kepler, 1997; Lau-
rent, 1997) suggest that the conformational transition of the
prion protein proceeds via multimeric assembly of the
pathogenic isoform of protein. However, the prion transfor-
mation mechanism has specific features not found in chem-
ical or enzymatic reactions: the product of the transforma-
tion is the catalyst itself. We therefore thought it is
important to investigate the effects of a large concentration
of catalyst on the dynamics of prion propagation.
We describe here a realistic, molecular prion model that
retains all the bistable properties previously described in the
simplest phenomenological models. However, this molecular
approach revealed additional new features of prion propaga-
tion. First, we found that the all-or-nothing transition induced
by input of the exogenous, pathogenic isoform of the prion
protein (contamination) corresponded to an irreversible transi-
tion. Second, by considering realistic values of kinetic con-
stants and parameters, we showed the existence of different
time scales in the dynamics of prion propagation. This time-
hierarchy provides a possible explanation as to how the mech-
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anism of prion protein conversion contributes to the long
incubation periods observed in prion diseases.
MODEL
Diagram 1 shows the overall mechanism suggested for
prion propagation. X is PrPC, the normal isoform of the
prion protein, and Y represents the converted, pathogenic
PrPSc species (Y and Yd are the monomer and dimer forms
of PrPSc, respectively). Conversion between the normal and
pathogenic forms of the protein occurs via two different
mechanisms: 1) A first-order reaction s  ksX correspond-
ing to spontaneous conversion. The rate constant ks is as-
sumed to be very low, consistent with the observed low
frequency of sporadic prion diseases. 2) An activated pro-
cess of conformational change in which the homodimer Yd
is the effective catalyst. Conversion occurs via the forma-
tion of an intermediary complex YdX.
These reactions are thought to occur in an open system in
which the X-species turns over (input rate ix and first-order
output rate ox  koxX). To make our model representative of
several different situations, we considered the possible exis-
tence of an input flux iy of the pathogenic species Y. A
non-null value of iy would mimic the occurrence of contam-
ination. Amyloid plaques consisting of aggregates of the
pathogenic isoform would then be formed through the oy
output process (first-order rate constant koy). Alternatively, this
step may be associated with an unknown process of seques-
tration or the slow elimination of this pathogenic isoform.
Four- and two-variable systems
The changes in the concentrations of the species over time
are described by four differential equations:
dX
dt
 ix ks koxX kxX  Yd kxYdX (1a)
dY
dt
 iy ksX kcYdX 2kyYd kyY2 koyY
(1b)
dYd
dt
 kcYdX kxX  Yd kxYdX kyYd kyY
2
(1c)
dYdX
dt
 kxX  Yd kxYdX kcYdX (1d)
Due to the presence of the Y2 and X  Yd terms, these
equations are nonlinear. Assuming rapid equilibrium both
for the dimerization of Y (equilibrium constant Ky ky/ky)
and for the binding of X on the Yd species (equilibrium
constant Kx kx/kx), this system reduces to a two-variable
system. To reduce the number of parameters, dimensionless
variables and parameters may be defined. We chose the
following normalization:
xT
XT
Kx
, yT
YT
Kx
, x
X
Kx
, y
Y
Kx
, yd
Yd
Kx
,
ydX
YdX
Kx
,   kct,  
ks
kc
, x
kox
kc
, (2)
y
koy
kc
, 	 
Kx
Ky
, x
ix
kcKx
, y
iy
kcKx
The equations of motion for the normalized, two-variable
system are thus,
dxT
d
 x   x 	y
2x g1x, y,
dyT
d
 y   	y
2x yy g2x, y,
(3)
DIAGRAM 1.
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with the two conservation equations:
xT x 	xy
2 f1x, y,
yT y 2	y21 x f2x, y.
(4)
The independent variables xT and yT represent the normal-
ized, total (bound and unbound species) concentrations (ex-
pressed as monomer concentrations) of the normal and
pathogenic forms of the prion protein, respectively. The
numerical integration of Eq. 3 would require the solution,
for each step of integration, of the system of nonlinear Eq.
4. For calculations, it is easier to consider x and y (the
concentrations of the corresponding unbound species) as
independent variables in place of xT and yT. We can write
dxT
d


f1

x
dx
d


f1

y
dy
d
 x   x 	y
2x g1x, y,
dyT
d


f2

x
dx
d


f2

y
dy
d
 y   	y
2x yy g2x, y.
(5)
We can define vectors [U] and [G] and matrix [J] as
U dx/ddy/d ; G g1g2 ;
J  j11 1 	y2 j12 2	xyj21 2	y2 j22 1 4	y1 x  .
(6)
Because [U]  [J]1  [G], the differential system can be
explicitly written as
dx
d

j22g1 j12g2
j11j22 j12j21
,
dy
d

j11g2 j21g1
j11j22 j12j21
.
(7)
Numerical integrations of differential Eq. 7 were carried out
with the Runge–Kutta fourth-order algorithm, with auto-
matic step-size control and control of the relative error of
integration at each step of the procedure.
Semi-parametric curves of steady states
h(y, pk)  0 in the plane [(log)pk, (log)yT]
The equation h(y, pk)  0, where pk represents any param-
eter of the model, may be obtained by eliminating the
variable x between quasisteady-state equations g1(x, y)  0
and g2(x, y)  0, in which expressions for g1(x, y) and
g2(x, y) are given in Eq. 3. We obtain
hpk, y y yy  x 	y2 x  	y2 0,
(8)
with the condition
y yy 0f y y/y. (9)
The roots of Eq. 8 are obtained numerically.
RESULTS
Existence of multiple steady states in the
prion system
The bistable characteristics of this prion model are shown in
Fig. 1 A. Steady states are defined by constant values for the
concentrations of the species. For the set of parameter
values we used (and also over a wide range of other values),
X- and Y-null isoclines have three intercepts, defining three
steady states for the system. Normal mode analysis (Appen-
dix A) demonstrates that any steady state (such as SS2)
corresponding to the part of the Y-null isocline that has a
negative slope is unstable. Such steady states correspond to
a saddle point (i.e., a simple threshold). Conversely, SS1 and
SS3 are stable steady states and behave as attractors. SS1 is
associated with a low concentration yT of the pathogenic
isoform of the prion protein. It may be defined as a normal
(nonpathogenic) state. Conversely, SS3 corresponds to a
high concentration (note the log scale in Fig. 1 A) yT of the
pathogenic prion protein Y. This steady state is a pathogenic
state.
Figure 1 A also shows that the concentrations of unbound
molecular species are significantly different from the total
concentrations (bound and unbound) of the corresponding
species. This difference seems to increase as the concentra-
tion of pathogenic isoforms increases: it is not significant in
SS1 and SS2, whereas free and total concentrations are
clearly different in the SS3 steady state. For instance, the
concentration of total, normal prion (xT) is about ten thou-
sand times higher than the free concentration of X (x) in the
SS3 steady state. In these conditions, autocatalytic conver-
sion predominates over spontaneous conversion (or the pro-
cess induced by the exogenous input of pathogenic species
in contamination), resulting in a very high concentration of
the ternary complex YdX (this concentration must be negli-
gible in the classical formulation of enzyme catalysis).
Thus, phenomenological rate equations derived from en-
zyme kinetics cannot be used to interpret prion behavior
over the whole concentration range during infection and
contamination.
Depending on the value of the input rate x of the normal
prion protein, the X- and Y-null isoclines have either one or
three intercepts, and the system therefore has either one or
three steady states (Fig. 1 B). Hence, the parameter depen-
dence of the singularity or multiplicity of steady states must
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be considered with respect to the values of the main param-
eters of the model.
Sporadic diseases are associated with reversible,
bistable transition
The semi-parametric curves in Fig. 2 show the dependence
of the number and properties of the steady states of the
system on several parameters. In each case, we observed the
existence of a wide range (3–4 orders of magnitude) of
values for which three (two stable and one unstable) steady
states co-existed. For each of these parameters, there are
two distinct limiting values beyond which the system pos-
sesses a single steady state. Beyond one of these values this
single steady state corresponds to a normal (nonpathogenic)
steady state because the concentration yT of the pathogenic
prion species is low. Beyond the other limiting value the
steady state corresponds to a pathogenic steady state in
which the concentration yT of the pathogenic isoform is
high.
As shown in Appendix B, explicit parametric conditions
can be found for the existence of bistability in this model:
x	 8 and x [xl, xu] or yl
 y
 yu with limiting
values xl, xu, yl, and yu as given in Appendix B; and
	 	 27(y/x)
2 and xl 
 x 
 xu with limiting values
xl and xu as given in Appendix B. Hence, in this model,
the conditions for the possible existence of several steady
states do not depend on the efficiency of the catalyzed
conversion. The condition x 	 8 seems to be satisfied in
all cases. Thus, the rate of degradation (x) of the normal
prion protein must be eight times higher than the rate of
spontaneous conversion of X into Y (). Indeed, the spon-
taneous conversion associated with the rare instances of
sporadic disease is known to be a very slow process (annual
background death rate of 0.5–1.5 per million for
Creutzfeldt–Jakob Disease). In contrast, the normal prion
protein is degraded rapidly, with an estimated half-life of
1 h (Borchelt et al., 1990).
The parametric conditions for the 	 value are easily
satisfied if 	 
 1 (Fig. 2 C), i.e., if the affinity of the
pathogenic dimer Yd for the normal species X is higher than
that of the pathogenic monomer for itself (Yd formation). In
such conditions, the bistability domain corresponds to about
six orders of magnitude of possible 	 values. Conversely,
FIGURE 1 Phase plane analysis of the prion system showing the existence of multiple steady states. Curves show the quasi-steady-state lines (null
isoclines) defined by equations g1(x, y)  0 and g2(x, y)  0. Expressions for g1(x, y) and g2(x, y) are given in Eq. 3. The corresponding equations were
solved numerically. (A) The two null isoclines in the (log xT, log yT) plane (thick lines) or in the (log x, log y) plane (thin lines). Variables xT and yT
correspond to the total (bound and unbound) concentration of the normal and pathogenic isoforms of the prion protein, respectively. Variables x and y
represent the concentrations of the corresponding unbound isoforms. Free and total concentrations of the species appear quite different for high
concentrations of the pathogenic isoform (in SS3 steady state for instance), whereas they are not distinguishable for low values of y (as in SS1 and SS2 steady
state for instance). (B) The singularity (thin lines) or multiplicity (thick lines) of steady states, according to the value of the input rate (x) of the normal
isoform of the prion protein. Note that the value of the input rate affects only the shape of the g1 null-isocline, without modifying the shape or position
of the g2 null-isocline. A single, normal steady state SS1(a) exists for a low value of x (x  10
4, null-isocline g1(a)). A single but pathogenic steady state
SS3(b) exists for a high value of x (x  1, null-isocline g1(b)). For a medium value of the input rate (x  0.05, g1 null-isocline), three steady states, SS1,
SS2 and SS3, coexist. Curves were obtained with the following set of values:   10
9, x  0.1, y  10
4, 	  0.1, x  0.05, y  0. We thus assume
the absence of contamination due to the input of exogenous, pathogenic prion (y parameter).
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the range of the bistability domain is less than one order of
magnitude for 	 values if we assume that the equilibrium
constants for the two types of multimeric assembly are
inversely related.
As an example, we will describe the rationale and prop-
erties of this system for variations in the input rate x of the
normal prion protein. Let us assume that the system is
initially in the normal SS1 steady state and that a continuous
increase in the input rate x occurs (Fig. 2 A, closed ar-
rows). Provided that x does not exceed the limiting value
xu, yT (and also xT), concentrations are slightly readjusted
to remain constant, consistent with the curve forming the
trajectory of steady states. However, if x exceeds the
threshold xu, the system moves to the SS3 domain of
stability, in which there is a high concentration yT of the
pathogenic species. This results in the appearance of a
strong discontinuity for the transition between the normal
and pathogenic steady states following a continuous in-
FIGURE 2 Trajectories of yT steady states in several semiparametric planes. Reversibility of the bistable transition. The variable is the input rate x of
the normal isoform of the prion protein (A), the output rate x of this normal isoform (B), the ratio 	 of equilibrium constants for the dimerization of the
pathogenic isoform and for the formation of the ternary, heterologous complex (C) or the output rate y for elimination of the pathogenic isoform (D). In
each case, the domain of bistability is limited by two distinct threshold values of the variable (see Appendix B). Upon increase (black arrows) or decrease
(white arrows) of the variable, the system undergoes a transition from one stable solution to the other (vertical dashed lines). The lower steady-state branch
corresponds to the normal steady state because it is associated with low values of the total concentration yT of the pathogenic isoform of the prion protein.
The upper branch of the trajectory is associated with high concentrations of Y isoform and corresponds to pathogenic steady states. The jump-like transitions
between normal and pathogenic steady states occur at different threshold values of the variable, according to the direction of movement along the trajectory.
This is typical of reversible, hysteretic bistable behavior. Curves were calculated with the following set of values of the parameters (standard values, except
for the variable tested):   109, x  0.1, y  10
4, 	  0.1, x  0.05, y  10
9.
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crease in the value of x. Let us now assume that the system
is initially in a pathogenic steady state, with a high x value,
and that a continuous decrease in the input rate x occurs
(Fig. 2 A, open arrows). A switch is observed between the
pathogenic and normal states, but the “jump-like” transition
occurs at a lower threshold value (xl) than that which
triggered the forward transition. Hence, the threshold values
of x are different for the forward and backward switches
between the normal and pathogenic steady states. These
threshold effects and hysteretic behavior are typical of the
bistable properties of the prion system.
Similar behavior is observed upon variation of the x, 	,
and y parameters (Fig. 2, B to D, respectively). This
enables us to propose a possible, simple explanation for the
occurrence of sporadic prion diseases. Such diseases prob-
ably correspond to: a change in the turnover rate for the
normal prion protein (x or x parameters), a decrease in the
rate of elimination of the pathogenic isoform of the protein
(y parameter), or a change in the binding constants asso-
ciated with dimerization of the pathogenic isoform or the
equilibrium constant associated with the interaction be-
tween the pathogenic dimer and the normal isoform of the
prion protein (	 parameter). The last two possibilities imply
that the definition of a healthy organism requires clarifica-
tion. It is currently thought that a healthy organism pos-
sesses no molecules of the pathogenic isoform of the prion
protein and that a single molecule would suffice to propa-
gate the infection. Dynamics show that a healthy organism
need not necessarily have a null concentration of the patho-
genic isoform, but only a low concentration of this species,
below the lower threshold.
Contamination results in irreversible transition
This prion model behaves differently if we assume that the
disease results from an initial, exogenous supply (y param-
eter) of the pathogenic isoform of the prion protein, as in
contamination processes. The bifurcation diagram obtained
if y is the variable (Fig. 3) differs qualitatively from those
of Fig. 2. The branch of steady states corresponding to high
concentrations yT of the pathogenic species is not connected
to the lower branch of stability corresponding to normal,
low yT concentration. There is thus no lower limiting point
corresponding to the threshold value (yl) for the backward
bistable transition.
If the system is in the normal SS1 steady state and the
input rate y of exogenous, pathogenic prion protein in-
creases such that it crosses the threshold yc, the system will
settle into the pathogenic SS3 steady state (Fig. 3, closed
arrows). However, if the perturbation is reversed (decrease
in the value of y), the system cannot switch back to the
normal SS1 steady state (Fig. 3, open arrows), even if y
reaches zero. The transition from the normal to the patho-
genic steady state triggered by any contamination process is
therefore irreversible.
Careful monitoring (data not shown) of the changes over
time in concentration of all the molecular species and of the
rate of each of the individual steps in Diagram 1 provides
insight into the mechanism underlying this irreversible tran-
sition. If y increases such that the concentration of the
exogenous pathogenic isoform Y exceeds its threshold
value, the concentration x of the unbound, normal isoform
of the protein suddenly decreases. At the same time, there is
a dramatic increase in the concentration y of the unbound,
pathogenic isoform. This increase in y exceeds by several
orders of magnitude the exogenous supply. It therefore
corresponds to internal amplification of the perturbation.
The system then slowly relaxes toward the stationary con-
centrations corresponding to the pathogenic SS3 steady
state. The concentrations of Y and Yd isoforms are now so
high that almost all the molecules of X are bound to form a
binary or ternary complex with the pathogenic isoforms. In
these conditions, Y production essentially results from the
internal autocatalytic process of transformation and the con-
tribution of the external supply of Y (y) becomes negligi-
ble. This is why the transition cannot be reversed, even if
y  0.
FIGURE 3 Trajectories of yT steady states when the input rate y of the
exogenous, pathogenic isoform is the variable. Irreversibility of the bist-
able transition induced by a contamination process. When y is the vari-
able, the pathogenic, SS3 steady-state branch corresponding to high yT-
concentrations of the pathogenic isoforms is not connected to the lower
branch of stability corresponding to normal, SS1 stable steady states. The
lower threshold value of y does not exist. Hence, increasing the input rate
y facilitates the jump-like transition from the normal to the pathogenic
steady state (black arrows) but decreases (white arrows) in the value of this
parameter (even to zero) do not provoke the reverse transition. The bistable
transition that follows contamination is irreversible. The values of the
parameters are as in Fig. 2.
2522 Kellershohn and Laurent
Biophysical Journal 81(5) 2517–2529
Time hierarchy contributes to the duration of the
incubation period in prion diseases
The mechanism of contamination by exogenous prion pro-
tein described above suggests that there is a time hierarchy
in this model. This means that the system involves several
simultaneous reactions that are not independent and that
occur at very different rates.
Close to the normal SS1 steady state, the concentrations
of the binary Yd and ternary YdX complexes are much lower
than those of the unbound species, X and Y (Fig. 1 A). There
is therefore no coupling of the metabolism of the normal X
and pathogenic Y isoforms of the prion protein in the YdX
complex in these conditions. Such metabolic coupling is
ensured only by the spontaneous conversion of X into Y (
parameter). However, this conversion is very slow (because
the frequency of sporadic prion diseases is low). The un-
bound species X is therefore relaxed (i.e., its concentration
is in a quasi-steady state) whereas the concentration of Y has
not yet stabilized. In these conditions, the differential sys-
tem of nonlinear Eq. 7 may be approximated by a system of
two independent, linear differential equations,
dx
d
 x   xx  x xx,
dy
d
 y y yy,
(10)
where x*1 vy cste (x*1 is the x concentration in the new
steady state). The solution of Eq. 10 is (starting from initial
conditions   0, x(0)  x0, y(0)  y0):
x()
x
  x
1 e(x) x0e(x),
y()
y y
y
1 ey y0ey,
(11)
with stationary values,
x*1
x
  x

x
x
, y*1
y vy
y
. (12)
If the system is beyond the transition threshold or close to
the SS3 (pathogenic) steady state, differential Eqs. 3 remain
coupled, but may be simplified as (see discussion above)
dxT
d
 x 	xy
2 g1x, y,
dyT
d
 	xy2 yy g2x, y.
(13)
In the SS3 steady state, we have
x 	x*y*2 yy*. (14)
We checked that the simplified expressions gave the same
patterns of change over time as were obtained with the
unsimplified differential system, for the range over which
they could be applied.
Figure 4 shows the changes in time of yT concentration on
two different time scales, after a transient, suprathreshold
perturbation-induced bistable transition from the normal,
SS1 steady state to the pathogenic, SS3 state. In the short
term (insert), the Y species seemed to relax rapidly, i.e.,
their concentration rapidly adopted an apparent, quasi-
steady state. However, on a longer time scale, we observed
that the pathogenic species relaxed much more slowly to
their true, final steady state.
The correspondence between dimensionless and real non-
normalized parameters may be assessed by isolating the
subsystem consisting purely of the biosynthesis and degra-
dation processes involving the normal isoform X of the
prion protein. In the absence of the pathogenic isoform Y,
changes in this subsystem over time are described by the
differential equation,
dx1
d
 x xx1. (15)
If we assume that this subsystem is displaced from its steady
state (x*1  x/x) by a slight perturbation x1
(0), we can
write
d
d
x*1 x1()
dx*1
d

dx1()
dt
f1(x*1)df1dx1*x1()Ç Ç
 0  0
(16)
and then
x1() x1
(0)ex. (17)
The relaxation time x is such that x  1/x, and so, 1/2 
x ln 2  ln 2/x. The value of x used in our simulations
(x  0.1) leads to x  10 and 1/2  6.93 (in normalized
time units). According to Borchelt et al. (1990), the exper-
imental relaxation time of the normal isoform of the prion
protein is close to 20 min. Hence, one unit of normalized
time corresponds to approximately 2 min.
In these conditions, 1/2 for the relaxation of the patho-
genic species Y (Fig. 4) would correspond to one year. After
2.5 years, the concentration yT of these species would be
only 80% of their final, steady-state concentration. These
calculations are approximate because the neurophysiologi-
cal processes that follow the accumulation of the pathogenic
isoform may cause an additional lag time. However, they
demonstrate that a simple dynamic model, based only on the
conversion of the normal to the pathogenic isoform of the
prion protein, is sufficient to account for very slow changes (on
the time scale of about a year) in the concentration of the
molecular species. Such a time scale is consistent with the
length of the incubation period observed in prion diseases.
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DISCUSSION
The infectiousness of scrapie has been shown to be inde-
pendent of the structures required for amyloid formation
(Wile et al., 2000). However, models of infection based on
a small, finite size of the catalytic PrPSc oligomer are often
thought to be less likely to reflect the reality than nucleated
polymerization models (Harper and Lansbury, 1997; Serio
et al., 2000; Masel et al., 1999). This is because small
finite-size models do not adequately account for the long
incubation periods observed (Porcher and Gatto, 2000). In
this study, we considered an oligomer-based model of this
type brought close to physiological conditions, in which the
concentrations of bound and unbound molecular species
were clearly distinguished. We have shown that, in these
conditions, the pathogenic isoform of the prion protein may
relax very slowly over a time scale consistent with the
incubation periods observed in animals. Death generally
occurs soon after the onset of the disease, which occurs in
the late stages of PrPSc accumulation (Beringue et al.,
2000). Hence, the long incubation times of prion diseases,
corresponding to years or even decades, may be at least
partly related to the slow rate of an elementary step in the
physicochemical conversion of the prion protein. However,
these long incubation periods may result from complex
biology rather than elementary, physicochemical processes.
This dynamic analysis suggests a possible mechanism for
sporadic prion diseases and for certain specific features
observed on contamination. In the proposed model, sporadic
prion diseases correspond to changes in the rate of turnover
of the normal isoform of the protein or, alternatively, in one
of the parameters associated with metabolism of the patho-
genic isoform. In accordance with this mechanism, it was
shown that mice expressing high levels of PrP transgenes
develop neural disorders (Westaway et al., 1994). The fre-
FIGURE 4 Long incubation periods in prion diseases due to a time hierarchy in the process of conversion of the protein. Initially (  0), the system
is assumed to be in the normal steady state, SS1, in which the concentration of the PrP
Sc isoform (yT variable) is very low. The contamination process is
simulated by adding a pulse of PrPSc beyond the SS2 threshold (insert, black arrow). The form of the perturbation (continuous or instantaneous) and time
for which it is applied would have no effect. The possible occurrence of the bistable transition depends only on the nature of the perturbation below or above
the SS2 threshold. Immediately after a suprathreshold perturbation, yT-concentration increases markedly (insert), due to amplification of the pulse. In the
short term (insert), the concentration of the Y species seems to arrive rapidly at a quasi-stationary value. However, this value corresponds to only 10%
of that in the final, SS3 steady state (note the log scale in the insert). If the variation of yT-concentration is observed over a longer time scale (main figure),
it becomes apparent that this variable relaxes slowly toward the SS3 steady state. The gray box near   0 in the main figure illustrates the extent of the
scale used in the insert in x and y coordinates. The basis of the setting of the correspondence between dimensionless () and real time units is described
in the text. Curves were calculated (using the standard values of the parameters given in Fig. 2) by numerical integration of simplified Eq. 10 (insert) or
13 (main Figure). No difference would be observed in these changes over time if the complete system of Eq. 7 was used on both time scales.
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quency of the [URE3] phenotype (a yeast prion) is increased
by overexpressing the URE2 gene and also by creating a
mutant of the Ure2 protein (Fernandez-Bellot et al., 2000).
One consequence of bistability is the absence of a snowball
effect in the autocatalytic propagation of the pathogenic
isoform provided that the concentration of both the patho-
genic and normal isoforms remain below a certain thresh-
old. It was experimentally shown that cell lines producing
low steady-state levels of PrPC protein were unable to
propagate prions in transgenic mice (Korth et al., 2000).
Consistent with our model, Manuelidis and Manuelidis
(1993) reported the prevalence of small amounts of the
pathogenic isoform of the prion protein in human lympho-
cytes. Immunohistochemical staining recently revealed the
presence of the pathogenic isoform of the prion protein in
the brains, nictitating membranes, and tonsils of two of
seven healthy sheep (Kim et al., 2001). This raised the hope
that such an immunohistochemical technique could be used
for the early diagnosis of scrapie infection in sheep before
the appearance of clinical signs. The results of our analysis
do not support this view because they indicate that healthy
organisms are not necessarily totally free of the pathogenic
isoform. Thus, the presence of a small amount of the PrPSc
isoform does not necessarily indicate an asymptomatic but
infectious pathogenic state. This is also consistent with the
recent proposal of Prusiner’s group that the normal, native
state of the prion protein may be marginally stable or
unstable (Harrison et al., 2001). However, in the absence of
amenable experimental data, we cannot give a quantitative
estimate of the nonpathogenic, basic level of PrPSc isoform
that might be present in the normal steady state.
From an experimental point of view, observation of dis-
tinct threshold values upon continuous forward and back-
ward variations of a control parameter is the best test to
demonstrate the existence of a reversible bistable transition
(Laurent and Kellershohn, 1999). Such an experiment may
be performed on the cellular [URE3] prion-like system, by
modifying the controlled expression of the URE2 gene.
Development of a permanent cell line supporting propaga-
tion of prion diseases is a prerequisite to develop such an
experiment in the case of the prion protein. A recent report
on a rabbit epithelial cell line (Vilette et al., 2001) seems to
open up a promising avenue for such an approach.
Our results also relate to contamination processes. Al-
though little is known about the precise mechanisms by
which flocks and herds become contaminated with patho-
genic prions, it is widely accepted that the ingestion of
contaminated food is a major route of dissemination of
prion diseases. Indeed, the rationale behind the policy of
killing the entire herd if one cow is found to be contami-
nated with the agent of bovine spongiform encephalopathy
(BSE) is that all the animals received the same food. How-
ever, clinical signs of the disease are generally detected in
only one animal, or at most a small number of animals. Our
model suggests a possible explanation for this surprising
observation. The animals of the herd may differ in the
parameters relating to metabolism of the prion protein. Most
of the animals would be able to eliminate spontaneously
amounts of the pathogenic isoform below the threshold
ingested with their food, returning to the normal steady state
after contamination. However, for some individuals with
slight differences in prion metabolism, the same amount of
contamination might be sufficient to reach the threshold and
to provoke the disease. Typical populations of sheep seem
to be closer to the threshold for pathogenic transition than
typical populations of cows, because 10 to 15% of sheep in
scrapie-infected flocks are often found to be contaminated,
whereas the proportion of BSE-contaminated animals is
generally much lower in cows.
At the population level, sporadic prion diseases and con-
tamination processes are likely to share a number of impor-
tant features. In all cases, the number of individuals that
develop the disease depends on the heterogeneity of the
population for the parameters relating to metabolism of the
prion protein and the extent to which the mean value for
these parameters deviates from the corresponding threshold
value. However, other features differentiate sporadic dis-
eases from contamination processes. Sporadic Creutzfeldt–
Jakob Disease and the form resulting from transmission of
the BSE agent to humans (new-Creutzfeldt–Jakob Disease)
can be distinguished at the molecular level. We have pre-
viously shown (Laurent, 1998; Kellershohn and Laurent,
1998) that conformational adaptation of the prion protein
may, in a bistability context, account for the main charac-
teristics of this species barrier. In this paper, we also show
that the bistable process observed upon contamination (in-
put of exogenous, pathogenic isoform of the prion protein)
corresponds to an irreversible bistable transition, whereas
sporadic disease corresponds to a reversible, hysteretic tran-
sition. How important is this difference?
Irreversible transitions between multiple steady states
have been studied in a variety of biochemical systems (for
a review, see Laurent and Kellershohn, 1999). In the context
of prion diseases, it is important to define precisely how this
transition is irreversible. A transition is irreversible if the
system cannot switch back to its previous steady state when
the perturbation is reversed. As illustrated here for varia-
tions of the input rate y of the pathogenic isoform of the
prion protein, this occurs if one stable steady-state branch is
not connected to the other stable branch. In the specific
model studied here, we have shown that irreversibility re-
sults in alternation upon transition between two processes:
exogenous PrPSc supply and autocatalytic, internal PrPSc
production. Even if the exogenous supply is stopped, there
is no effect on internal production after the transition has
occurred, rendering this transition irreversible. However,
the system selects one mode of operation in an irreversible
manner only for a given set of parameter values. In the
context of prion diseases, there may be situations in which
the system would return to a normal steady state after
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contamination has occurred, by acting simultaneously on
several variables and parameters. This would correspond,
for instance, to “cure” experiments (essentially performed in
prion-like systems such as the [URE3] nonchromosomal
genetic element in yeast (Edskes et al., 1999)). In this
system, not only is the external supply of pathogenic iso-
form stopped, but all existing pathogenic isoforms are also
removed from the system. However, in the case of the prion
protein itself, the possible reversion of the bistable transition
does not necessarily imply that the neurophysiological dis-
orders that occurred when the system was in its pathogenic
steady state will also be reversed. The distinction between
reversible and irreversible bistable transitions would be-
come important if we could experimentally detect early
stages of infection, before the occurrence of neurological
disorders.
APPENDIX A
Normal mode analysis of differential Eq. 7
For a small perturbation (x, y) close to the stationary values x* and y*
of system 7, we can write
dx/ddy/d  B*xy , (A1)
where [B]* is the Jacobi matrix associated with differential Eq. 7, in which
the value of each element b*ij is calculated at steady state. We have:
det(J)*b*11 j*22
g1
x 
*
 j*12
g2
x 
*
;
det(J)*b*12 j*22
g1
y 
*
 j*12
g2
y 
*
;
det(J)*b*21 j*11
g2
x 
*
 j*21
g1
x 
*
;
(A2)
det(J)*b*22 j*11
g2
y 
*
 j*21
g1
y 
*
;
with
 j*11 1 	y*2; j*12 2	x*y*,j*21 2	y*2; j*22 1 4	y*1 x*, (A3)
and


g1/
x*  x 	y*2;

g1/
y*2	x*y*,

g2/
x*   	y*2;

g2/
y* 2	x*y* y.
(A4)
The eigenvalues of the Jacobi matrix are determined by the characteristic
equation
r2 b*11 b*22r b*11b*22 b*12b*21
 r2 tr(B)*r det(B)* 0, (A5)
where tr(B) is the trace and det(B) the determinant of the Jacobi matrix. It
follows from Eq. A5 that the signs of the eigenvalues, and therefore the
stability behavior of the system, are defined uniquely by the two terms
tr(B) and det(B), which are complex functions of kinetic parameters.
Determinant det(B)*  b*11b*22  b*12b*21 of the
Jacobi-matrix
According to Eq. A2, we can write
det2J*  det(B)* j*22
g1
x 
*
 j*12
g2
x 
*
 j*11
g2
y 
*
 j*21
g1
y 
*
 j*22
g1
y 
*
 j*12
g2
y 
*
 j*11
g2
x 
*
 j*21
g1
x 
* , (A6)
which leads to
det2J*  det(B)*
j*11j*22 j*12j*21Ç
det(J)* 
g1
x 
*
g2
y 
*

j*11j*22 j*12j*21Ç
det(J)* 
g1
y 
*
g2
x 
*
, (A7)
and then
det(J)*  det(B)* 
g1
x 
*
g2
y 
*
 
g1
y 
*
g2
x 
*
. (A8)
Every partial derivative in Eq. A8 may be expressed as a function of y* as
a single variable (taking into account the relationship between stationary x*
and y* values). Thus,
det(J)*  det(B)*   	y*2y1 x  	y*2

2x	y*
  	y*22
yy* y . (A9)
The expression denoted by {. . .} in the right-hand term of Eq. A9 corre-
sponds to the stationary expression of the derivative dx/dy. Hence,
det(J)*  det(B)*   	y*2dxdy *. (A10)
Because
det(J)* j*11 j*22 j*12 j*21
 1 	y*21 4	y* 4	x*y* 0
(A11)
every stationary value, in the semi-parametric plane (x, y) or (log x, log
y), located in the region of negative slope of the trajectory of steady states,
is associated with a negative value of the determinant of the Jacobi matrix.
Conversely, the regions of positive slope of this curve are associated with
det(B)* 	 0.
2526 Kellershohn and Laurent
Biophysical Journal 81(5) 2517–2529
The condition det(B)* 
 0 means that the roots r1 and r2 of the
characteristic Eq. A5 do not have the same sign. Because, in these condi-
tions, we also have tr*2(B)  4 det(B)* 	 0, these roots are necessarily
real. We can conclude that any steady state for which det(B)* 
 0 is an
unstable steady state corresponding to a saddle point.
Trace tr(B)*  b*11  b*22 of the Jacobi matrix
Considering Eqs. A2–A4, we can write
det(J)*  tr(B)* j*22
g1
x * j*12
g2
x *
 j*11
g2
y * j*21
g1
y *, (A12)
which leads to
det(J)*  tr(B)*
x1 4	y*1 x*
   	y*21 2	y*1 3x*
 y1 	y*2
 2	x*y*1 3	y*2Ç
 0 . (A13)
Eq. A13 indicates that the sign of the trace of the Jacobi matrix may change
when the system moves from one steady state to another. The local stability
of steady states in the (log x, log y) semi-parametric plane is shown in Fig.
5, for a standard set of parameter values. In this plane, the trajectory of
Y-steady states is represented, together with the lines tr(B)*  0 and
det(B)*  0. These lines divide the plane into three domains (note that
everywhere in this plane, the discriminant *  tr2(B)  4 det(B)* is
positive):
(1) tr(B)* 
 0 and det(B)* 	 0 Stable node
(2) tr(B)* 
 0 and det(B)* 
 0 Saddle point
(3) tr(B)* 	 0 and det(B)* 
 0 Saddle point
Stationary values of y* in the region of positive slope of the curve log y*
 f(log x) are located in domain (1). Hence, corresponding SS1 and SS3
steady states are locally stable. Conversely, stationary values of y* in the
region of negative slope of the curve log y*  f(log x) are located in
domain (2). So, SS2 steady states are locally instable and correspond to
saddle points.
APPENDIX B
Parametric conditions for the coexistence of
multiple steady states
The multiplicity of steady states in this model is associated with the
S-shape of the graphs log y* (or log y*T) f(log pk) (in which pk represents
any of the x, x, y, 	 parameters). This S-shape is conserved in non-
logarithmic coordinates. For each of these parameters, we can write an
explicit function F( ) such as pk  F(y, plk). Hence, the condition for the
coexistence of multiple steady states is equivalent to the condition for the
existence of two real, positive roots for the equation F(y)  0 (in which F
is the first derivative F with respect to y). Calculations were performed
under the simplifying assumption y  0 (absence of exogenous contam-
ination). By eliminating variable x between null-isoclines g1(x, y)  0 and
g2(x, y)  0 derived from Eq. 3, we obtain the polynomial equation,
hy yy  x 	y
2 x  	y
2
 yy x  	y
2 xyy 0 (B1)
with the condition
yy x 07 y x/y. (B2)
x as a control parameter
We can write, from Eq. B1,
x Fy yy
  x 	y
2
  	y2
 yy1 x  	y2 ,
(B3)
and then
dx
dy
 Fy y1 x  	y2 2x	y
2
  	y22 , (B4)
Fy 0f 	y22 x 2	y2   x 0.
(B5)
The discriminant of Eq. B5 is positive when

x

1
8
. (B6)
FIGURE 5 Parameter regions of the prion system represented in Dia-
gram 1 with different stability properties. The trajectory of steady states
and the curves tr(B)*  0 and det(B)*  0 obtained from normal mode
analysis of differential Eq. 7 are represented in the (log y, log x) semi-
parametric plane. The SS1 and SS3 steady states both correspond to stable
nodes because they are in the white region of the plane in which the trace
of the Jacobi matrix is negative and its determinant is positive. Conversely,
the SS2 steady state is unstable: it corresponds to a saddle point because it
lies in the light gray region of the plane in which both the determinant and
the trace of the Jacobi matrix are negative. The dark gray region of the
plane (in which there is no steady state) corresponds to an unstable node
region (as we have tr(B)* 	 0 and det(B)* 	 0). Curves were calculated
using the standard values of the parameters given in Fig. 2.
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The roots of Eq. B6 are
y1  12	 x 2  xx 8
1/2
,
and y2  12	 x 2  xx 8
1/2
, (B7)
with y2 	 y1 	 0. The limit x values are then
xu yy11 x  	y12
and xl yy21 x  	y22 . (B8)
Condition B6 is necessary for the existence of multiple steady states in this
model. This condition becomes necessary and sufficient if we add the
supplementary condition for x,
x xl, xu. (B9)
x as a control parameter
We can write, from Eq. B1,
xy Fy   	y
2	 xyy 1
 , (B10)
under the condition
y x/y. (B11)
The derivative F(y) is
Fy
dx
dy

1
yy
2 x	y
2 2y	y3 x. (B12)
y-values for which the derivative F(y) is null are the roots of the equation,
Gy 2y	y3 x	y2 x 0. (B13)
Descartes’ sign rule shows that Eq. B13 cannot have more than two real,
positive roots for y. Taking into account the condition B11, graphical
analytical evaluation of G(y) shows that the condition for the existence of
these two roots is
	  27	yx

2
. (B14)
The necessary and sufficient condition to obtain multiple steady states
when x is the control parameter, is expressed by Eq. B14 with the limiting
values of x such that
xl x xu, (B15)
with
xl x(yy1)   	y1
2	 xyy1 1

and xu x(yy2)   	y2
2	 xyy2 1
 , (B16)
where y1 and y2 are the two roots of Eq. B13.
y as a control parameter
We can write, from Eq. B1,
yy Fy
x  	y
2
y  x 	y
2
, (B17)
and then
dy
dy
 Fy
x2	y2  x 	y2   	y2  x 3	y2y2  x 	y22  .
(B18)
The condition F(y)  0 leads to the same equation as does Eq. B5. Thus,
the necessary and sufficient condition for the existence of multiple steady
states when y is the control parameter is expressed by Eq. B6 with the
limiting values of y, such that
yl y yu, (B19)
with
yl yy y1
x  	y1
2
y1  x 	y1
2
and yu yy y2
x  	y2
2
y2  x 	y2
2
, (B20)
in which expressions of y1 and y2 are given by Eq. B7.
	 as a control parameter
We can write, from Eq. B1,
	y
1
y2 xyyx yy  , (B21)
and then
d	
dy
 Fy

2  xyy2 x4  xyy 2x
2
y3x yy
2 .
(B22)
The condition for the existence of two real, positive roots for equation
F(y)  0 is identical to the condition expressed in Eq. B5. Under this
condition, the coordinates of the extremes for the 	(y) function are
y1
x
4y  x
4  x xx 8;
	1
1
y1
2 xyy1x yy1  ;
y2
x
4y  x
4  x xx 8;
	2
1
y2
2 xyy2x yy2  . (B23)
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